Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

N Engl J Med. 2016 Mar 17;374(11):1094. doi: 10.1056/NEJMc1600827.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzhydryl Compounds / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucosides / therapeutic use*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents